ALKS
Price
$28.85
Change
-$0.15 (-0.52%)
Updated
Jul 3 closing price
Capitalization
4.55B
16 days until earnings call
CLCFF
Price
$0.04
Change
-$0.01 (-20.00%)
Updated
Jul 2 closing price
Capitalization
3.96M
Interact to see
Advertisement

ALKS vs CLCFF

Header iconALKS vs CLCFF Comparison
Open Charts ALKS vs CLCFFBanner chart's image
Alkermes
Price$28.85
Change-$0.15 (-0.52%)
Volume$1.12M
Capitalization4.55B
Christina Lake Cannabis
Price$0.04
Change-$0.01 (-20.00%)
Volume$100.3K
Capitalization3.96M
ALKS vs CLCFF Comparison Chart in %
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. CLCFF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and CLCFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ALKS: $28.85 vs. CLCFF: $0.04)
Brand notoriety: ALKS and CLCFF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 67% vs. CLCFF: 218%
Market capitalization -- ALKS: $4.55B vs. CLCFF: $3.96M
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. CLCFF’s [@Pharmaceuticals: Other] market capitalization is $3.96M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 2 FA rating(s) are green whileCLCFF’s FA Score has 1 green FA rating(s).

  • ALKS’s FA Score: 2 green, 3 red.
  • CLCFF’s FA Score: 1 green, 4 red.
According to our system of comparison, ALKS is a better buy in the long-term than CLCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 3 TA indicator(s) are bullish while CLCFF’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 3 bullish, 6 bearish.
  • CLCFF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLCFF is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +0.07% price change this week, while CLCFF (@Pharmaceuticals: Other) price change was +3.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than CLCFF($3.96M). CLCFF YTD gains are higher at: 148.667 vs. ALKS (0.313). ALKS has higher annual earnings (EBITDA): 519M vs. CLCFF (-1.34M). ALKS has more cash in the bank: 773M vs. CLCFF (1.53M). CLCFF has less debt than ALKS: CLCFF (6.45M) vs ALKS (372M). ALKS has higher revenues than CLCFF: ALKS (1.66B) vs CLCFF (10.3M).
ALKSCLCFFALKS / CLCFF
Capitalization4.55B3.96M115,011%
EBITDA519M-1.34M-38,729%
Gain YTD0.313148.6670%
P/E Ratio8.90N/A-
Revenue1.66B10.3M16,146%
Total Cash773M1.53M50,556%
Total Debt372M6.45M5,767%
FUNDAMENTALS RATINGS
ALKS: Fundamental Ratings
ALKS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
38
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALKSCLCFF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
63%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
63%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLCFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUOCX29.540.29
+0.99%
Morgan Stanley Instl US Core C
GSURX63.870.54
+0.85%
Goldman Sachs US Equity Insights R
AMRMX60.100.38
+0.64%
American Funds American Mutual A
LMVRX120.830.47
+0.39%
ClearBridge Value R
HLHIX27.610.07
+0.25%
Virtus KAR Health Sciences Inst

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with ESPR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then ESPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-0.52%
ESPR - ALKS
38%
Loosely correlated
+1.74%
COLL - ALKS
35%
Loosely correlated
-0.52%
PAHC - ALKS
34%
Loosely correlated
+0.21%
VTRS - ALKS
33%
Loosely correlated
-0.21%
DVAX - ALKS
33%
Loosely correlated
+1.08%
More

CLCFF and

Correlation & Price change

A.I.dvisor tells us that CLCFF and ALKS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLCFF and ALKS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLCFF
1D Price
Change %
CLCFF100%
N/A
ALKS - CLCFF
23%
Poorly correlated
-0.52%
RGC - CLCFF
21%
Poorly correlated
+121.91%
LVZPF - CLCFF
6%
Poorly correlated
N/A
HYEX - CLCFF
6%
Poorly correlated
N/A
GEDSF - CLCFF
6%
Poorly correlated
N/A
More